Suneva Medical

SUNEVA MEDICAL ANNOUNCES 12-MONTH SAFETY RESULTS FROM PIVOTAL ARTEFILL® ACNE SCAR INVESTIGATIONAL CLINICAL STUDY

SUNEVA MEDICAL ANNOUNCES 12-MONTH SAFETY RESULTS FROM PIVOTAL ARTEFILL® ACNE SCAR INVESTIGATIONAL CLINICAL STUDY Dermal Filler Appears to be a Safe Treatment for Acne Scars SANTA BARBARA, Calif. (Jan. 7, 2014)—Suneva Medical Inc., a privately-held aesthetics company, today announced the 12-month follow-up data from its randomized, double-blinded, multi-center, Pivotal acne scar investigational study evaluating the…

Suneva Medical

Suneva Medical Signs Multi-Million dollar Line of Credit Agreement

Suneva Medical Signs Multi-Million dollar Line of Credit Agreement with Western Technology Investment Additional Financing Used to Fund Suneva’s Growth SAN DIEGO, CA – December 17, 2009 – Suneva Medical, a privately-held aesthetic medical device company, today announced that it has signed a multi-million dollar line of credit facility with Western Technology Investment (WTI). The…

Suneva Medical

Study Results Evaluating the Correction of Atrophic Scars with Artefill

Study Results Evaluating the Correction of Atrophic Scars with Artefill Presented at 2010 Orlando Dermatology Conference Study Suggests Artefill® Provides an Effective and Potentially Long-Lasting Treatment Option for Acne Scar Patients SAN DIEGO, CA – January 18, 2010 – Suneva Medical, a privately-held aesthetic medical device company, provided a research grant to support an investigator-sponsored…

Suneva Medical

Suneva Medical Announces Positive Interim Data

Suneva Medical Announces Positive Interim Data from Five-Year Safety and Patient Satisfaction Study on Artefill® – Study Suggests Artefill Is As Safe as Other Dermal Fillers for Nasolabial Fold Correction – – Data Presented at Maui Derm 2010 Meeting – MAUI, HAWAII — January 25, 2010 – Suneva Medical, a privately-held aesthetic medical device company,…

Suneva Medical

Two Studies Find Artefill® to Be a Long-Term Treatment

Two Studies Find Artefill® to Be a Long-Term Treatment Option for Facial Lipoatrophy Investigator-Initiated Studies Examine Artefill’s Use with Age-Related and HIV-Associated Facial Lipoatophy Patients SAN DIEGO, CA – February 2, 2010 – Suneva Medical, a privately-held aesthetic medical device company, today announced that two clinical studies suggest Artefill may be a safe, effective, long-term…

Suneva Medical

Leading U.S. Dermatologist Reports Positive Data on Artefill®

Leading U.S. Dermatologist Reports Positive Data on Artefill® Dr. Christopher Zachary Discusses Interim Data from Artefill Five-Year Safety and Patient Satisfaction Study at the Hawaii Dermatology Seminar SAN DIEGO, CA – February 16, 2010 – Suneva Medical, a privately-held aesthetic medical device company, today announced that Christopher B. Zachary, MBBS, FRCP, Professor and Chair, Department…

Suneva Medical

Leading Plastic Surgeons Report Positive Data on Artefill® at Key Society Meetings

Leading Plastic Surgeons Report Positive Data on Artefill® at Key Society Meetings SAN DIEGO, CA – May 4, 2010 – Suneva Medical, a privately-held aesthetic medical device company, today announced that Steven R. Cohen, M.D., F.A.C.S, Clinical Professor, University of California, San Diego and John H. Joseph, M.D., F.A.C.S, Assistant Clinical Professor, UCLA, presented interim…

Suneva Medical

Suneva Medical Announces Publication of ArteFill® Five-Year Safety

Suneva Medical Announces Publication of ArteFill® Five-Year Safety and Patient Satisfaction Study Interim Results in Dermatologic Surgery SAN DIEGO, CA – May 5, 2010 – Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of interim results from its long-term study on ArteFill in the May 2010 issue of Dermatologic Surgery, the…

Suneva Medical Announces Canadian Approval of BellaFill®

SAN DIEGO, CA – June 29, 2011 – Suneva Medical, a privately-held aesthetic medical device company, today announced the expansion of its core aesthetics injectable business with approval from Health Canada to market BellafillTM, its long lasting dermal filler for nasolabial folds or smile line correction. In addition to offering patients a unique, long-lasting treatment,…

Suneva Medical

Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals

Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals Refissa Leads Suneva into the Topical Aesthetic Market SAN DIEGO, CA – May 21, 2012 – Suneva Medical, a privately-held aesthetics company, today announced that it has acquired an aesthetic product portfolio from Spear Pharmaceuticals (“Spear”). Under the terms of the agreement, Suneva will acquire worldwide rights…